Executive officer

Philip P. Boudreau

Executive Vice President, Finance and Chief Financial Officer·Abbott Laboratories

About

Philip P. Boudreau has served as Executive Vice President, Finance and Chief Financial Officer of Abbott since 2024, having been Senior Vice President, Finance and Chief Financial Officer from 2023 to 2024 and Vice President, Finance and Controller from 2020 to 2023. He joined Abbott in 1997 and was elected a corporate officer in 2020.

Since 2024
Age 53
Tenure 2 yrs

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director RM Robert J. Alpern, M.D. Director CB Claire Babineaux-Fontenot Director SP Sally E. Blount, Ph.D. Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director

Roles

Organization Role Dates Details
Abbott Laboratories Executive Vice President, Finance and Chief Financial Officer 2024–present Current role
Abbott Laboratories Senior Vice President, Finance and Chief Financial Officer 2023 to 2024
Abbott Laboratories Vice President, Finance and Controller 2020 to 2023
Abbott Laboratories Divisional Vice President, Controller, Medical Devices 2017 to 2020
Abbott Laboratories Divisional Vice President, Controller and Commercial Support, Point of Care Diagnostics 2012 to 2017
Abbott Laboratories Controller roles in Point of Care Diagnostics, Nutrition and Diabetes Care Held earlier in his Abbott career after joining in 1997.

Related

Company Abbott Laboratories Company hub Person Nita Ahuja, M.D. Director Person Robert J. Alpern, M.D. Director Person Claire Babineaux-Fontenot Director Person Sally E. Blount, Ph.D. Director Person Robert B. Ford Chairman of the Board and Chief Executive Officer; Director Person Paola Gonzalez Director Person Michelle A. Kumbier Director Person Darren W. McDew Director Person Nancy McKinstry Lead Independent Director Person Michael G. O'Grady Director Person Michael F. Roman Director Person Daniel J. Starks Director Deal Abbott Laboratories Advanced Medical Optics 2009 Deal page Deal Abbott Laboratories Alere 2017 Deal page Deal Abbott Laboratories Basf S Pharmaceutical Business Knoll 2001 Deal page
Source: Abbott Laboratories SEC filings and official company website

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo